Ikarian Capital, LLC Cumberland Pharmaceuticals Inc Call Options Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPIX
# of Institutions
39Shares Held
4.42MCall Options Held
185KPut Options Held
6.8K-
Israel Englander Millennium Management LLC | New York, Ny810KShares$3.81 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny503KShares$2.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA417KShares$1.96 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX252KShares$1.19 Million0.0% of portfolio
-
J. Goldman & CO LP New York, NY241KShares$1.14 Million0.03% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $69.1M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...